Hypoxia inducible factor-1 alpha and carbonic anhydrase IX overexpression are associated with poor survival in breast cancer patients

Journal of B.U.ON.

Volumn 17, Issue 4, 2012, Pages 663-668

  Kaya, Ali Osman ^a   Gunel, N ^a   Benekli, M ^a   Akyurek, N ^a   Buyukberber, S ^a   Tatli, H ^a   Coskun, U ^a   Yildiz, R ^a   Yaman, E ^a   Ozturk, B ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Breast cancer; CA IX; HIF 1 ; Prognosis; Tumor hypoxia

Indexed keywords

CARBONATE DEHYDRATASE IX; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MENOPAUSE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; BREAST NEOPLASMS; CARBONIC ANHYDRASES; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MIDDLE AGED; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 84872379495     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Aebersold DM, Burri P, Beer KT et al. Expression of hypoxia-inducible factor-1 alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res 2001; 61: 2911-2916. (Pubitemid 32691934)
2. Axelson H, Fredlund E, Ovenberger M et al. Hypoxia-induced dedifferentiation of tumor cells - a mechanism behind heterogeneity and aggressiveness of solid tumors. Semin Cell Dev Biol 2005; 16: 554-563. (Pubitemid 41247879)
3. Bachtiary B, Schindl M, Pötter R et al. Overexpression of hypoxia-inducible factor 1 alpha indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer. Clin Cancer Res 2003; 9: 2234-2240. (Pubitemid 36687648)
4. Brennan DJ, Jirstrom K, Kronblad A et al. CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance. Clin Cancer Res 2006; 12: 6421-6431. (Pubitemid 44799714)
5. Cianfrocca M, Goldstein LJ. Prognostic and predictive factors in early-stage breast cancer. Review. The Oncologist 2004; 9: 606-616. (Pubitemid 39546402)
6. Generali D, Fox SB, Berruti A et al. Role of carbonic anhydrase IX expression in prediction of the efficacy and outcome of primary epirubicin/tamoxifen therapy for breast cancer. Endocr Relat Cancer 2006; 13:921 -930.
7. Graeber TG, Osmanian C, Jacks T et al. Hypoxia mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 1996; 379: 88-91. (Pubitemid 26008141)
8. Huang AL. Hypoxia: a key regulatory factor in tumour growth. Nat Rev Cancer 2002; 2:38-47.
9. Jemal A, Tiwari RC, Murray T et al. Cancer statistics 2004. CA Cancer J Clin 2004; 54: 8-29.
10. Kronblad A, Jirström K, Rydén L et al. Hypoxia inducible factor-1 alpha is a prognostic marker in premenopausal patients with intermediate to highly differentiated breast cancer but not a predictive marker for tamoxifen response. Int J Cancer 2006; 118: 2609-2601.
11. Rosen PP, Groshen S, Saigo PE et al S. Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years. J Clin Oncol 1989; 7:1239-1251. (Pubitemid 19220125)
12. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003; 3: 721-732. (Pubitemid 37328811)
13. Smart CR, Byrne C, Smith RA et al. Twenty-year follow-up of the breast cancers diagnosed during the Breast Cancer Detection Demonstration Project. CA Cancer J Clin 1997; 47: 134-149. (Pubitemid 27226280)
14. Struewing JP, Hartge P, Wacholder S et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.N Engl J Med 1997; 336: 1401-1408. (Pubitemid 27208598)
15. Swinson DE, Jones JL, Richardson D et al. Carbonic anhydrase IX expression, a novel surrogate marker of tumour hypoxia, is associated with a poor prognosis in non-small cell lung cancer. J Clin Oncol 2003; 21:473-482. (Pubitemid 46613490)
16. Trastour C, Benizri E, Ettore F et al. HIF-1 alpha and CA IX staining in invasive breast carcinomas: Prognosis and treatment outcome. Int J Cancer 2007; 120: 1451-1458. (Pubitemid 46355379)
17. Unruh A, Ressel A, Mohamed HG et al. The hypoxia-inducible factor-1 alpha is a negative factor for tumor therapy. Oncogene 2003; 22: 3213-3220. (Pubitemid 36712933)
18. Wykoff CC, Beasley NJ, Watson PH et al. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 2000; 60: 7075-7083. (Pubitemid 32059187)